HUM — Neutral (ASignal Rank 3/4)
ASignal's 10+ AI agent pipeline rates HUM as Neutral with 78% confidence in the Healthcare sector.
AI Analysis Summary
Avoid HUM due to extreme leverage and deteriorating fundamentals despite positive technical momentum
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade D — 25/100
- Bill Ackman (Activist Investing): Grade B — 61/100
- Ray Dalio (Macro/Risk Parity): Grade B — 65/100
Consensus: Bearish
Price Intelligence
- Current price: $215.23
- Price target: $237.97 (+10.6%)
- Risk level: high
- Horizon: short term
Quality Assessment
- Balance sheet: concerning
- Cash flow: good
- Competitive moat: none
Peer Group Analysis
HUM is in the “Quality Cash Generators” cluster alongside YUM, WYNN, USB, VICI, V (96 stocks total). 2 of 96 peers are currently bullish.